ZNF875
Zinc finger protein 875
Also known as: HKR1, ZN875_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10072
- Gene
- ZNF875
- Ensembl
- ENSG00000181666
- Chromosome
- 19
- Canonical length
- 659 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
659 residues, UniProt reviewed canonical sequence.
>P10072|ZNF875
1 MRVNHTVSTM LPTCMVHRQT MSCSGAGGIT AFVAFRDVAV YFTQEEWRLL SPAQRTLHRE
61 VMLETYNHLV SLEIPSSKPK LIAQLERGEA PWREERKCPL DLCPESKPEI QLSPSCPLIF
121 SSQQALSQHV WLSHLSQLFS SLWAGNPLHL GKHYPEDQKQ QQDPFCFSGK AEWIQEGEDS
181 RLLFGRVSKN GTSKALSSPP EEQQPAQSKE DNTVVDIGSS PERRADLEET DKVLHGLEVS
241 GFGEIKYEEF GPGFIKESNL LSLQKTQTGE TPYMYTEWGD SFGSMSVLIK NPRTHSGGKP
301 YVCRECGRGF TWKSNLITHQ RTHSGEKPYV CKDCGRGFTW KSNLFTHQRT HSGLKPYVCK
361 ECGQSFSLKS NLITHQRAHT GEKPYVCREC GRGFRQHSHL VRHKRTHSGE KPYICRECEQ
421 GFSQKSHLIR HLRTHTGEKP YVCTECGRHF SWKSNLKTHQ RTHSGVKPYV CLECGQCFSL
481 KSNLNKHQRS HTGEKPFVCT ECGRGFTRKS TLSTHQRTHS GEKPFVCAEC GRGFNDKSTL
541 ISHQRTHSGE KPFMCRECGR RFRQKPNLFR HKRAHSGAFV CRECGQGFCA KLTLIKHQRA
601 HAGGKPHVCR ECGQGFSRQS HLIRHQRTHS GEKPYICRKC GRGFSRKSNL IRHQRTHSGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF875 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 130 nTPM
Expression across tissuesHPA
Tissue
- retina: 130 nTPM
- choroid plexus: 52 nTPM
- prostate: 38 nTPM
- thyroid gland: 36 nTPM
- cerebellum: 36 nTPM
- adrenal gland: 36 nTPM
Single-cell type
- cardiomyocytes: 322 nCPM
- rod photoreceptor cells: 241 nCPM
- cone photoreceptor cells: 217 nCPM
- choroid plexus epithelial cells: 157 nCPM
- retinal bipolar cells: 108 nCPM
- sertoli cells: 99 nCPM
Immune cell
- MAIT T-cell: 14 nTPM
- naive CD4 T-cell: 14 nTPM
- T-reg: 13 nTPM
- basophil: 13 nTPM
- naive B-cell: 12 nTPM
- naive CD8 T-cell: 12 nTPM
Brain region
- choroid plexus: 110 nTPM
- cerebellum: 86 nTPM
- hypothalamus: 75 nTPM
- cerebral cortex: 73 nTPM
- white matter: 72 nTPM
- basal ganglia: 71 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.44
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF875 as an antibody target. Whether an autoantibody or antibody against ZNF875 could matter depends on whether native ZNF875 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF875 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF875 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...